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Abstract
Background: The Hirschsprung’s disease Anorectal malformation QoL questionnaire (HAQL) is a disease-specific
quality of life (QoL) questionnaire for patients with Hirschsprung’s disease (HD) or anorectal malformations (ARM). It
was originally proposed in Dutch and is currently being translated into other languages to obtain an internationally
standardized instrument. In this work we validate a French adaptation of the HAQL for adolescents and adults.
Methods: The questionnaires were translated into French and sent to patients aged 12 years and older, followed
for HD or ARM at three French university hospitals. Questionnaires were sent to 147 adolescents and 188 adults.
The psychometric properties of the questionnaires were analyzed in terms of reliability and validity.
Results: The original HAQL structure was not satisfactory. A new structure was proposed, while aiming to remain
close to the original structure. The proposed structure has acceptable reliability and validity properties and reflects
both physical, as well as psychosocial aspects.
Conclusions: A French version of the HAQL questionnaire for adults and adolescents is ready for use in France. In
particular the score could discriminate between degrees of clinical status based on the Krickenbeck consensus,
which can aid clinicians to inform patients about physical and psychosocial challenges they may expect.
Keywords: Anorectal malformation, Cultural adaptation, Disease-specific questionnaire, HAQL, Hirschsprung’s
disease, Krickenbeck, Quality of Life
Background
Hirschsprung’s disease (HD) and anorectal malforma-
tions (ARM) are rare congenital defects which occur
during fetal development and which can have life-long
consequences. Both conditions require neonatal surgery
and some patients may need a colostomy (stoma). How-
ever, even a very successful anatomic repair may not be
able to ensure optimal bowel control, urinary control, or
sexual functioning. For patients with lasting functional
digestive symptoms, regular follow-up is required and
bowel management programs involving enemas and
dietary restrictions have been developed to improve their
quality of life (QoL) [1].
QoL evaluation tools are useful to aid further treat-
ment decisions for such patients, as well as to support a
reassessment of their prognosis. They are also useful to
facilitate further research on the QoL of these patients,
for example to identify subgroups of patients with a high
risk of a low QoL and to understand how any QoL
related problems can be prevented or managed.
Whereas general QoL questionnaires are available,
disease specific measures provide greater sensitivity
and specificity. Therefore, in 2001, Hanneman and
colleagues constructed the Hirschsprung’s disease
Anorectal malformation QoL questionnaire (HAQL), a
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self-report instrument to assess QoL in patients with
HD or ARM [2]. They proposed different versions of
the questionnaire depending on the age of the patient:
a proxy form for children of 6, or 7 years old, a proxy
and a patient form for children of 8 to 11 years old
and adolescents of 12 to 16 years old and a patient
form for adults of 17 years and older.
The HAQL was originally formulated in Dutch. To
ensure an internationally standardized evaluation tool,
the questionnaires are being translated and culturally
adapted to other languages such as Italian and Swedish
[3, 4]. The child version for children of 6 to 11 years
old has been translated to French and was validated in
a study by Clermidi and colleagues [5]. The aim of the
present study is to validate a French translation of the
child and proxy questionnaires for patients from 12 to
16 years old (HAQL12–16 and HAQLproxy) and the adult
form for patients of 17 years and older (HAQL17+).
Methods
Original HAQL questionnaires
The original HAQL questionnaires cover physical,
emotional and social functioning, as well as disease-
related symptoms [2]. The HAQL12–16 is composed of
nine dimensions (40 items) [2, 6]: laxative diet (two
items), constipating diet (two items), presence of diarrhea
(two items), fecal continence (eight items), urinary con-
tinence (four items), social functioning (five items), emo-
tional functioning (six items), body image (two items)
and physical symptoms (nine items). For the adults, the
questionnaire is composed of ten dimensions (41 items):
the nine same dimensions as the HAQL12–16 (with small
differences in the number of items in the social function-
ing (three items) and the emotional functioning (seven
items) dimensions) and a sexual functioning dimension
(two items).
For each item the response is scored from 0 to 3 and
linearly transformed to a 0 to 100 scale, so that higher
scores indicate a better QoL. The scores for the dimen-
sions are computed as the sum of the item scores, di-
vided by the number of items answered, conditional on
that more than 50% of the items are answered. If infor-
mation on all dimensions is available for a patient, a
total score can be computed as the sum of the scores of
the dimensions.
For patients with a stoma, an extra section is included
related to the stoma (eight items). These patients are
asked to skip part of the questions (22 items) for pa-
tients without a stoma, since these questions are not
relevant for them, e.g. questions related to going to the
toilet.
The questionnaires were translated into French using
standard methodology [7–9].
Study design
All patients followed for HD or ARM at the University
Hospitals of Nantes, Angers and Paris-Necker (French
center of expertise for anorectal and rare pelvic malfor-
mations) were contacted if they were aged 12 or older in
April 2011. In accordance with the exclusion criteria
used by Hanneman and colleagues [2], patients were
excluded if they had a cloaca, were mentally retarded, or
lacked a basic proficiency in French.
Patients received a mail with the appropriate HAQL
questionnaires and a generic questionnaire on QoL: the
Vécu et Santé Perçue de l’enfant et de l’Adolescent
questionnaire (VSPA) [10] for adolescents and the short
version of the World Health Organization Quality Of
Life questionnaire (WHOQOL BREF) [11] for adults. In
addition, they received an information letter, a face
validity questionnaire and a questionnaire containing
the Krickenbeck criteria [12] to measure clinical status.
After two weeks, all patients received a conditional
reminder asking them to return the questionnaire if
they hadn’t done so yet. Four weeks after the initial
mail, all patients received another mail including only
an information letter and the HAQL and clinical status
questionnaires (retest step).
The research protocol has been validated by an ethical
committee: the Groupement Nantais d’Ethique dans le
Domaine de la Santé (GNEDS) which is specialized in
non-interventional studies. The protocol is registered
under the reference 2011-06-01.
Evaluation of the French version of the HAQL
All statistical analyses were performed in SAS® (version
9.3, SAS Institute Inc.) and R version 3.2.2. Data are
expressed by mean ± standard deviation. The significance
level was fixed at 0.05. All correlations are expressed in
Pearson’s correlation coefficient (denoted by ρ).
Validity
The validity of the French translation of the HAQL was
assessed in terms of face validity, concurrent validity and
construct validity. The content validity of the HAQL
was considered by Hanneman et al. [2] for the Dutch
versions of the questionnaires. It was not re-evaluated
for the French questionnaires, since cultural differences
between the Dutch and French populations are minor, in
particular concerning questionnaires based on the im-
pact of symptoms on Health related QoL. Experts at the
three French University Hospitals did not underline any
problems concerning the content validity.
Face validity verifies whether the questionnaire ap-
pears relevant and comprehensible to the participants. It
was assessed through a small questionnaire sent to all
patients in the study, which evaluated response time and
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whether there were any problems to understand the
questions.
Construct validity indicates whether the structure of the
questionnaire (the relations between items and dimen-
sions) is valid. It was studied using a multitrait-scaling
analysis (MTS) and known-groups validity. The MTS
analysis in particular assessed convergent and divergent
validity, considering that each item should be highly corre-
lated with its own dimension (ρ > 0.40), and should be
more correlated with its own dimension than with others.
Concurrent validity compares an instrument with an
established measure of the same, or a closely related
construct. It was assessed by considering the correlations
between the dimensions of the French HAQL and the
generic QoL measures VSPA and WHOQOL BREF. The
concurrent validity was considered satisfactory if the
correlation between two close dimensions was higher
than 0.40.
Known-groups validity evaluates whether an instrument
can discriminate between known groups of patients that
are expected to score differently on the measure of inter-
est. It was assessed by comparing the mean scores of
known groups of patients for each HAQL dimension
using an ANOVA in case of multiple groups or Student’s
t-test when two groups were compared. The groups were
“disease status” (HD versus ARM) and groups based on
clinical status according to the Krickenbeck classification
(degrees of autonomy status, soiling, constipation and
voluntary bowel movement).
Reliability
The reliability of the questionnaires was evaluated in
terms of internal consistency and test-retest reliability.
Internal consistency assesses whether a questionnaire
measures a homogeneous concept by evaluating the
correlations between items. For each dimension, it was
measured by Cronbach’s α, where α > 0.70 was consid-
ered satisfactory [13].
Test-retest reliability evaluates the reproducibility of a
questionnaire, i.e. whether a patient who is tested repeat-
edly in a stable condition reports similar results. The
Intraclass Correlation Coefficient (ICC) was used to
measure the agreement between the two sets of HAQL
scores obtained from the patients at the start of the
study and 4 weeks later. An ICC > 0.60 was considered
satisfactory [13].
Finally, for adolescents, the concordance between the
patient and proxy outcomes was assessed based on the
ICC.
Methodology to propose a new structure
If validity of the original HAQL structure was not satisfac-
tory, a new structure would be proposed based on the MTS
analysis and expert opinions. To ensure comparability
across countries, an effort would be made to keep the
structure as close as possible to the original structure
proposed by Hanneman et al. [2]. The validity and reliabil-
ity of the new structure would be assessed using the same
methodology as described above.
Results
Response rates
One hundred forty-seven adolescent and proxy ques-
tionnaires and 188 adult questionnaires were sent out.
The response rate for the first mailing (test step) was
33% (n = 48) for the adolescents, 34% (n = 50) for their
proxies and 37% (n = 69) for the adults. The response
rate for the second mailing (retest step) for the patients
that had returned a questionnaire in the first step was
48% (n = 23) for the adolescents, 46% (n = 23) for their
proxies and 54% (n = 37) for the adults (see Fig. 1).
The percentage of HD patients was 12% (n = 8) for
adults and 33% (n = 16) for adolescents. Ten adults
Fig. 1 Flow-chart of patient inclusion in the study
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(14%) and three adolescents (6%) reported having a
stoma. Five other adolescents indicated that they did not
have a stoma, whereas their proxies indicated that they
did. Since priority should be given to the patient’s
answers [14] and since the questions for patients without
a stoma can be answered in a sensible way, even when
patients have a stoma, the answers of these patients to
these questions were included in the analysis, with the
exception of two patients who did not understand the
term stoma.
Dropout analysis
Patients which did or did not respond to the re-test step
were compared based on their responses for the test-
step. For each dimension and total score, a t-test was
performed to evaluate whether scores of responders and
non-responders differed. No significant differences were
found, although total scores were slightly higher for
non-responders (adolescents: 592 vs 623, p-value =
0.302, adults: 586 vs 652, p-value = 0.082). We therefore
expect that there is no relevant difference between these
patients and expect similar test-retest concordance re-
sults for patients with and without re-test responses.
We do not have sufficient information on patients
which did not respond to the test step to compare
them to the patients which did respond. Based on the
above comparison, we may expect that on average
non-responders are slightly less severe cases, although
differences are likely to be small. However, the sample
includes patients with extreme scores on the HAQL
questionnaire, which indicates that the sample covers
patients with a wide range of disease severity. For the
purpose of validation of the questionnaire, we there-
fore do not expect a bias in the results.
Face validity
The overall missing item response rate for the test step
was 4.8% for the adolescents, 4.0% for their proxies and
1.5% for adults. For the retest step, these rates were 0.1,
0.5 and 1.2% respectively. The items related to sexual
functioning had somewhat higher nonresponse rates
than the other items (around 10%). No other specific
item had an unusually high nonresponse rate. The aver-
age response times were 23.1, 25.6 and 19.8 min for ado-
lescents, proxies and adults respectively.
Seven adolescents (15%) and 11 adults (16%) reported
that the questions regarding urinary function were not
relevant. Moreover, three adolescents (6%) and 11 adults
(16%) mentioned that they considered the questions re-
garding a stoma either difficult or irrelevant. Two of these
adolescents had a stoma according to their parents, but
did not report having a stoma themselves. The remaining
adolescent and one of the adults reported having a stoma,
but considered the questions irrelevant. Finally, seven
adults (10%) reported that they found the questions about
their sexual functioning either intrusive or irrelevant.
Validity of the original structure
Because of the small number of patients with a stoma,
the questions concerning the stoma were not validated
in this paper. For the remaining items, Additional file 1:
Tables S1 and S2 in the appendix present the MTS ana-
lyses of the French translation of the HAQL question-
naires for adults, respectively adolescents. For the adults,
out of 41 items, three items have poor convergent valid-
ity and 11 do not have satisfactory divergent validity. In
particular, Dimension 8 “Body Image” performs poorly,
since neither item satisfies divergent validity. For Dimen-
sion 2 “Constipating diet”, one out of its two items does
not reach the validity criteria. For the adolescents, out of
40 items, five items have poor convergent validity and
24 do not reach divergent validity. Dimensions 2, 6 and
8 corresponding to “Constipating diet”, “Social function-
ing” and “Body Image” do not contain any items with
satisfactory validity properties.
The above validity results for the original HAQL
structure were considered unsatisfactory. Therefore, it
requires improvement before it can be used in France.
Proposition of a new structure
It was briefly assessed whether the HAQL structure pro-
posed by Clermidi et al. [5] for children between 6 and
11 years old was suitable for adolescents and adults. For
adults and adolescents respectively, MTS analyses re-
vealed that five, respectively six out of 25 items did not
meet convergent validity and ten, respectively 13 items
did not meet divergent validity. Since these results are
not better than the results for the original structure and
since it seems best for international comparability to re-
main as close as possible to the structure used in other
countries, it was decided to propose a new structure
based on the original HAQL, but with several modifica-
tions based on the MTS results and expert opinions:
 Dimensions 2 “Constipating diet” and 3 “Presence of
diarrhea” were grouped into one dimension, since
they are closely related and for adolescents, the
items in Dimension 2 correlated more strongly with
Dimension 3 than with their own dimension. For
adults Dimension 2 did not have satisfactory validity
properties either.
 Dimensions 7 “Emotional functioning” and 8 “Body
image” were grouped into one dimension, since the
items in Dimension 8 correlated more strongly with
Dimension 7 than with Dimension 8 for both adults
and adolescents and the dimensions are close.
 Items “loss of feces during emotional moments” and
“going to the toilet while having no urge”
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corresponding to item numbers 43 and 31
respectively for adolescents and 46 and 34 for adults,
were removed. Also, items “amorous feelings” and
“fantasize about making love” corresponding to item
numbers 17 and 18 for adolescents were removed.
These items had especially bad divergent as well as
convergent validity properties and there was no
clear indication that they could be moved to another
dimension.
 Item 9 “important to be in neighborhood of a toilet”
was moved from dimension “Fecal continence” to
“Emotional functioning” for both adults and
adolescents. This decision was based on that Item 9
correlated strongly with Dimension “Emotional
functioning” for both age groups, while it reached
neither convergent, nor divergent validity in its
former dimension.
The resulting proposed structure for adolescents con-
tains 36 items in 7 dimensions: Laxative diet, Presence
of diarrhea, Fecal continence, Urinary continence, Social
functioning, Emotional functioning and body image and
Physical symptoms. For adults it encompasses a total of
39 items, with 37 items in the same 7 dimensions, plus
one extra dimension “Sexual functioning” containing
two items (Additional file 1: Tables S3 and S4). Descrip-
tive statistics for the new scale can be found in Table 1.
Validity
Concurrent validity results for the proposed structure
can be found in Additional file 1: Tables S5 (adults) and
S6 (adolescents). For adults, all dimensions reached a
significant correlation > 0.40 with at least one close di-
mension from WHOQOL-BREF, except laxative diet
(significant, but low correlation) and urinary continence.
For adolescents, all HAQL dimensions significantly cor-
related with a coefficient > 0.40 to a relevant dimension
from VSPA. The dimensions “Relations with family”,
“School work” and “Relations with medical staff” from
VSPA did not correlate significantly with any HAQL
dimension.
The MTS analysis indicated that all items reached
convergent validity for adults and all items, except
Items 36 and 48, reached divergent validity (Additional
file 1: Table S7). For adolescents, all items satisfied
convergent validity, except Item 7 (ρ = 0.38). Divergent
validity was satisfactory for all but ten items (Additional
file 1: Table S8).
Results on known-groups validity can be found in Tables 2
(adults) and 3 (adolescents). Neither the overall score, nor
Table 1 Description and reliability of the HAQL proposed structures for adults and adolescents
HAQL dimensions N %
missing







Overall scale 51 26% 309 800 620.86 135.29 0.95 0.91 –
Adults
1 - Laxative Diet 68 1% 17 100 85.50 24.09 0.78 0.66 –
2 - Presence of Diarrhea 59 14% 0 100 77.69 22.85 0.76 0.90 –
3 - Fecal Continence 58 16% 6 100 82.88 21.83 0.88 0.86 –
4 - Urinary Continence 69 0% 0 100 91.17 18.79 0.91 0.75 –
5 - Social Functioning 59 14% 0 100 78.20 30.42 0.89 0.86 –
6 - Emotional Functioning
and Body Image
69 0% 3 100 64.01 28.00 0.93 0.88 –
7 - Physical symptoms 59 14% 0 100 60.85 23.77 0.86 0.83 –
8 - Sexual functioning 61 12% 0 100 81.18 29.52 0.94 0.78 –
Adolescents
Overall scale 42 12% 276 700 608.07 95.50 0.94 0.91 0.94
1 - Laxative Diet 48 0% 33 100 88.83 18.01 0.65 0.88 0.73
2 - Presence of Diarrhea 43 10% 17 100 83.35 25.09 0.88 0.73 0.92
3 - Fecal Continence 43 10% 28 100 85.70 18.92 0.85 0.92 0.86
4 - Urinary Continence 48 0% 58 100 97.60 7.29 0.78 0.93 0.71
5 - Social Functioning 42 12% 0 100 93.14 19.92 0.95 0.88 0.81
6 - Emotional Functioning
and Body Image
48 0% 19 100 84.17 20.69 0.91 0.91 0.82
7 - Physical symptoms 43 10% 17 100 71.77 18.67 0.80 0.79 0.74
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any of the dimensions were able to discriminate between
the disease statuses HD or ARM. For adults, the overall
score was not able to detect different autonomy statuses
(p = 0.2700), but could discriminate between different de-
grees of all other clinical status variables. All dimensions
could discriminate between groups of at least one variable,
except Dimension 4 “Urinary continence”. For each clinical
status variable, there were at least three dimensions which
could distinguish the different groups.
For adolescents, the overall score could discriminate
between different degrees of all clinical status variables.
The dimensions “Presence of diarrhea” and “Urinary
continence” could not discriminate between any groups.
All other dimensions could distinguish between groups
of at least one variable. For all clinical status variables
there were at least three dimensions that differed signifi-
cantly per group.
Reliability
Table 1 presents the reliability results for the proposed
structures. Internal reliability was satisfactory for all
dimensions, except for “Laxative diet” for the adoles-
cents (α = 0.65). Test-retest concordance was good for
all dimensions in both age groups. Responses from ado-
lescents and their proxies correlated strongly and signifi-
cantly. Their responses did not differ much, although
parents typically reported somewhat lower outcomes
(Fig. 2).
Discussion
In this paper a French translation of the Dutch Hirsch-
sprung’s disease Anorectal malformation QoL (HAQL)
questionnaire was validated for adults aged 17 years and
older and for adolescents, aged between 12 and 16 years.
The original structure was found to be unsatisfactory for
the French population. It was therefore briefly assessed
whether the structure proposed by Clermidi et al. [5] for
French children between 6 and 11 was more suitable. It
would be a practical advantage if one HAQL question-
naire would suffice in France. However, results were un-
favorable. This was expected, since the younger patients
are still learning how to cope with their complication [6]
and children typically have different priorities than older
age groups [13]. Therefore their perception of QoL and
their view on their complication may differ from adults,
such that one can expect that their QoL should be
assessed in a different way.
Finally, a modification of the original structure was
proposed, while an effort was made to stay close to the ini-
tial structure to optimize international comparability. For
adults, the proposed scale consists of 39 items in 8 dimen-
sions and for adolescents it consists of 36 items in 7 dimen-
sions. Dimensions relate to laxative diet, presence of
diarrhea, fecal continence, urinary continence, social func-
tioning, emotional functioning, body image and Physical
symptoms and sexual functioning (adults only).
The French translation was overall well received by
the patients. However, several patients indicated that
they did not understand the term “stoma”. For clarity,
the description of a stoma in the original questionnaire
“A stoma is a derivation of the intestine through the
skin, in order to make a short circuit” was changed to
“A stoma is a derivation of the intestine through the
skin, with a pocket to collect stools” in the new version
of the questionnaire.
Questions concerning urinary continence were often
considered irrelevant by the recipients. This is under-
standable, since urinary incontinence occurs only in a
minority of HD or ARM patients [1]. However, when
it occurs, it is likely to have an impact on a patient’s
QoL, such that it is important to keep this dimension
in the questionnaire. Questions about sexual function-
ing had a somewhat higher item nonresponse rate and
were reported to be considered irrelevant by a number
of patients. Considering the personal nature of such
questions, this may be expected. Since the sexual
items for adolescents performed badly, these questions
were removed from the questionnaire. Finally, for ado-
lescents, results from the patient and proxy question-
naires corresponded well, which suggests that there
are no age related problems with understanding the
questionnaire.
Fig. 2 Average outcomes (±2 x standard error) for the dimensions of the proposed HAQL score for adolescents and their proxies
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The statistical results for the proposed HAQL struc-
tures were overall satisfactory. Compared to the original
structure, the proposed structures contain fewer dimen-
sions with only two items (two instead of four). Since
dimensions with less than three items are typically un-
stable [15], this should result in a more robust structure.
Furthermore, reliability results were good, except for
dimension “Laxative diet”, where Cronbach’s alpha was
just below the threshold (and which is a dimension with
only two items). Regarding validity, concurrent validity
results were good. However, for adults, dimensions
“Laxative diet” and “Urinary continence” were not sig-
nificantly related to any dimensions of the WHOQOL-
BREF questionnaire. Dimension “Laxative diet” has also
been reported to perform suboptimal for the Dutch and
Italian version of the questionnaire [2, 3], which could
be explained by its small number of items. For dimension
“Urinary continence” there may be a lack of power to
detect significant correlations, since it is a rare functional
disorder. The performance of this dimension could im-
prove if a larger sample size would be investigated where
there is a better chance of observing this functional
disorder.
For adolescents, VSPA dimensions “Relations with
family”, “School work” and “Relations with medical staff”
did not correlate significantly with any HAQL dimen-
sion. This is somewhat surprising, since notably school
attitude has been noted to be worse for patients with
severe HD or ARM [6].
With respect to known-groups validity, dimension “Urin-
ary continence” could not discriminate between any known
groups of patients, which may be due to the aforemen-
tioned lack off observed urinary incontinence. The dimen-
sion “Laxative diet” did not correlate strongly with any
generic QoL dimension for adults. Unexpectedly, dimen-
sion “Presence of diarrhea” could not discriminate between
known groups for adolescents. Finally, neither the overall
score nor any of the dimensions could discriminate be-
tween disease statuses. This may simply be due to the small
number of HD patients in the sample (n = 16 adolescents,
n = 8 adults), such that the power to detect this group was
too low. Alternatively, it might indicate that QoL related
differences between HD and ARM patients are small, as
also suggested by Hartman et al. [6], although other works
question this lack of a difference in QoL [16].
Dimension “Emotional functioning and body image”
had the best ability to discriminate between groups. This
indicates that patients with varying clinical statuses differ
most strongly with regard to emotional functioning and
body image. This dimension was also one of the dimen-
sions that was most strongly correlated with the dimen-
sions of the generic QoL questionnaires for both adults
and adolescents. This is in line with results from Hartman
et al. [17], who identified psychosocial functioning and
self-esteem as one of the most important factors affecting
the generic QoL of patients with HD and ARM. This
highlights the importance of taking psychological conse-
quences for these patients into account.
The French HAQL questionnaire has been validated
on patients in France only. Naturally, it would be of
interest to use this version in other French speaking
countries. It would always be best to statistically validate
the questionnaires for each different culture to ensure
that they are well understood and interpreted. However,
many of the questions in the HAQL questionnaire are
directly related to the functioning of the body and are
not expected to result in different interpretations across
similar cultures (e.g. whether or not a patient lost feces
during the night). Therefore, although we recommend a
careful consideration of the questions to ascertain that
there are no concerns about misinterpretation, the ques-
tionnaire may be considered for use in French speaking
communities outside of France as well.
Conclusion
A French version of the Dutch HAQL questionnaire for
adults and adolescents is now ready for use in France. It
was found that patients with different grades of the
Krickenbeck clinical status variables scored differently
on the overall HAQL score and its dimensions. This can
be especially helpful to enable clinicians to better inform
their patients about the physical, social and emotional
challenges they might expect.
This newly validated French version of the HAQL
questionnaire provides a useful tool for further research
on the QoL of HD and ARM patients in France. Such
research could aid to answer questions such as whether
there are specific subgroups of patients with more severe
QoL related problems and what the consequences are of
a reduced QoL for HD and ARM patients. Also, poten-
tial differences in QoL between HD and ARM patients
could be explored further.
The HAQL is now available in the Netherlands, Italy,
Sweden and France. A first translation of the HAQL into
English has also been made, but needs further validation
[14]. To ensure an international QoL assessment tool
for HD and ARM patients, it would be highly interesting
to continue the translation of the HAQL questionnaire
into other languages.
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